Literature DB >> 11162589

Blockade of PKC epsilon activation attenuates phorbol ester-induced increase of alpha-secretase-derived secreted form of amyloid precursor protein.

S W Yeon1, M W Jung, M J Ha, S U Kim, K Huh, M J Savage, E Masliah, I Mook-Jung.   

Abstract

The role of PKC epsilon in amyloid precursor protein (APP) processing was investigated using APP-overexpressing B103 cells. As reported previously, a PKC activator, phorbol-12,13-dibutyrate (PDBu), enhanced secretion of APP alpha, and this effect was blocked by a PKC inhibitor, GF109203X in this system. Selective inhibition of PKC epsilon by overexpressing the PKC epsilon V1 region, which binds specifically to the receptor for activated C-kinase (RACK), blocked PDBu-induced enhancement of APP alpha secretion as well as PDBu-induced decrease in beta-secretase-derived APP C-terminal fragment production. On the other hand, the level of PKC epsilon, but not that of PKC alpha or PKC gamma, was substantially lower in the brains of Alzheimer's disease patients compared to age-matched controls. These results add to a growing body of evidence that PKC epsilon plays an important role in modulating APP processing, and suggest that reduced PKC epsilon activity may contribute to the development of Alzheimer's disease. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162589     DOI: 10.1006/bbrc.2000.4181

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.

Authors:  Amani Batarseh; Vassilios Papadopoulos
Journal:  Mol Cell Endocrinol       Date:  2010-06-30       Impact factor: 4.102

2.  Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activities.

Authors:  Dehui Duan; Dina M Sigano; James A Kelley; Christopher C Lai; Nancy E Lewin; Noemi Kedei; Megan L Peach; Jeewoo Lee; Thushara P Abeyweera; Susan A Rotenberg; Hee Kim; Young Ho Kim; Saïd El Kazzouli; Jae-Uk Chung; Howard A Young; Matthew R Young; Alyson Baker; Nancy H Colburn; Adriana Haimovitz-Friedman; Jean-Philip Truman; Damon A Parrish; Jeffrey R Deschamps; Nicholas A Perry; Robert J Surawski; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2008-08-13       Impact factor: 7.446

3.  Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon.

Authors:  Abhik Sen; Daniel L Alkon; Thomas J Nelson
Journal:  J Biol Chem       Date:  2012-03-17       Impact factor: 5.157

4.  PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice.

Authors:  Doo-Sup Choi; Dan Wang; Gui-Qui Yu; Guofen Zhu; Viktor N Kharazia; J Peter Paredes; Wesley S Chang; Jason K Deitchman; Lennart Mucke; Robert O Messing
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-12       Impact factor: 11.205

5.  Lysophosphatidic acid induces increased BACE1 expression and Aβ formation.

Authors:  Jing Shi; Yunzhou Dong; Mei-Zhen Cui; Xuemin Xu
Journal:  Biochim Biophys Acta       Date:  2012-10-02

6.  Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.

Authors:  René Etcheberrigaray; Mathew Tan; Ilse Dewachter; Cuno Kuipéri; Ingrid Van der Auwera; Stefaan Wera; Lixin Qiao; Barry Bank; Thomas J Nelson; Alan P Kozikowski; Fred Van Leuven; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

7.  Enhanced generation of Alzheimer's amyloid-beta following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C.

Authors:  Odete A B da Cruz e Silva; Sandra Rebelo; Sandra I Vieira; Sam Gandy; Edgar F da Cruz e Silva; Paul Greengard
Journal:  J Neurochem       Date:  2008-12-02       Impact factor: 5.372

Review 8.  Endosomal-lysosomal dysfunctions in Alzheimer's disease: Pathogenesis and therapeutic interventions.

Authors:  Shereen Shi Min Lai; Khuen Yen Ng; Rhun Yian Koh; Kian Chung Chok; Soi Moi Chye
Journal:  Metab Brain Dis       Date:  2021-04-21       Impact factor: 3.584

9.  Bryostatin-1 vs. TPPB: dose-dependent APP processing and PKC-α, -δ, and -ε isoform activation in SH-SY5Y neuronal cells.

Authors:  P Yi; L Schrott; T P Castor; J S Alexander
Journal:  J Mol Neurosci       Date:  2012-06-15       Impact factor: 3.444

10.  Protein kinase C-regulated aβ production and clearance.

Authors:  Taehyun Kim; David J Hinton; Doo-Sup Choi
Journal:  Int J Alzheimers Dis       Date:  2011-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.